Integrative Training Program for Pediatric Sickle Cell Pain
NCT06691867 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155
Last updated 2025-11-14
Summary
This research aims to answer the question: does a group training program specifically for teens with chronic sickle cell disease (SCD) pain that teaches skills to strengthen the mind and body help improve everyday functioning and reduce pain symptoms?
The program will be tailored to address challenges related to frequent or chronic sickle cell pain and may improve participants' physical and emotional health.
The program, called I-STRONG for SCD (Integrative Strong Body and Mind Training for Sickle Cell Disease), may help improve everyday functioning and pain symptoms in teens with chronic pain related to SCD. The research team aims to determine how participants (teens and parents) respond to this program.
Conditions
Interventions
- BEHAVIORAL
-
I-STRONG
I-STRONG is an evidence-based protocol from the FIT Teens program. This intervention combines mind-body and cognitive-behavioral approaches with neuromuscular movement training informed by pediatric sports medicine and injury prevention research. It aims to teach mind-body skills applicable during movement training to enhance psychological coping and reduce fear of pain and activity avoidance. I-STRONG consists of 16 group-based telehealth sessions held twice weekly over 8 weeks. Each group can accommodate up to 6 patients with SCD. Adolescents are expected to attend all sessions, while parents will attend 6 of the 16. Parents will receive education about I-STRONG, guidance on supporting their teen's behavior change, and opportunities for networking with other parents of youth with SCD. Sessions will include brief daily homework (e.g., using phone apps to practice skills) to facilitate proficiency. Participants will self-report their practice of assigned skills.
- OTHER
-
Enhanced Usual Care (EUC)
The EUC arm is designed to account for potential effects on time and standard medical care outcomes. Patients randomized to EUC will continue with standard care and optimal management of their SCD and chronic pain for approximately 8 months (i.e., time from enrollment through 6-month post-treatment assessment) before starting the intervention program to coincide with the study duration of the ES arm. After completing the 6-month follow-up assessment, patients will have the opportunity to start the I-STRONG for SCD intervention.
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
Emory University
lead OTHER
Principal Investigators
-
Soumitri Sil, PhD, ABPP · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-08
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- United States
Study Locations
More Related Trials
-
Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease
NCT01369160 ·Status: COMPLETED
-
Sickle Cell Pro-Inflammatory Response to Interval Training Study
NCT03653676 ·Status: COMPLETED
-
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
NCT00600665 ·Status: COMPLETED ·Phase: NA
-
Building Adaptive Coping and Knowledge to Improve Daily Life
NCT04602728 ·Status: COMPLETED ·Phase: NA
-
Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
NCT02987725 ·Status: COMPLETED ·Phase: NA
-
Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
NCT04156399 ·Status: TERMINATED ·Phase: NA
-
Pressure Pain Tolerance in Relation to Balance and Strength in Children
NCT06529874 ·Status: RECRUITING ·Phase: NA
-
Predictors of Pain in Sickle Cell Disease
NCT06139510 ·Status: RECRUITING ·Phase: NA
-
MBSR for Pain Catastrophizing in SCD
NCT02394587 ·Status: COMPLETED ·Phase: NA
-
Pain Management Protocol for Pediatric Sickle Cell Disease
NCT00386048 ·Status: COMPLETED
-
Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain
NCT01058473 ·Status: COMPLETED
-
School Readiness Intervention for Preschool Children With Sickle Cell Disease
NCT06367192 ·Status: RECRUITING ·Phase: NA
-
Low Systemic/High Local Exercise Load in Peds SCD
NCT06387758 ·Status: RECRUITING ·Phase: NA
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Pain in Sickle Cell Epidemiologic Study
NCT00035763 ·Status: COMPLETED
-
Genetics and Pain Severity in Sickle Cell Disease
NCT01441141 ·Status: COMPLETED
-
Telemedicine for Children With Sickle Cell Disease
NCT05087303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Near Infrared Spectroscopy in Sickle Cell Pediatric Patients
NCT04031521 ·Status: WITHDRAWN
-
Validation of the Sickle Cell Disease Pain Burden Interview
NCT00804362 ·Status: COMPLETED
-
Feasibility of a Stress Reduction Intervention Study in Sickle Cell Disease
NCT02501447 ·Status: COMPLETED ·Phase: NA
-
CHOICES3: Sickle Cell Disease Parenting CHOICES
NCT05292781 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients
NCT02571088 ·Status: COMPLETED ·Phase: NA
-
Assessing Function in Pediatric Patients With Sickle Cell Disease
NCT00590148 ·Status: COMPLETED
-
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
NCT01895361 ·Status: COMPLETED ·Phase: PHASE2
-
iPeer2Peer Program for Youth With Sickle Cell Disease
NCT03989986 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA